EST Biogen (BIIB) up 5% after EMA recommends Leqembi for early Alzheimer’s disease Published first on TheFly – the ultimate ...

Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal antibody directed against aggregated soluble ...

Taking Out OGA. The rationale behind small-molecule OGA inhibition is that these drugs will decrease tau hyperphosphorylation and aggregation into neurofibrillary tangles (right). [Courtesy of Eli ...

Hookle, a Finland-based tech company, is advancing sustainable growth for over 30 million U.S. micro-businesses with its AI-powered social media marketing app. By simplifying digital marketing, Hookle ...

A European regulatory committee now recommends approval of the Alzheimer’s treatment lecanemab a few months after rejecting ...

After re-examining its initial opinion, EMA’s human medicines committee, or CHMP, has recommended granting a marketing authorisation to Leqembi for treating mild cognitive impairment or mild dementia ...

Prior to ATP, Dr. Ehlers was Executive Vice President for Research and Development at Biogen, where he significantly grew and diversified Biogen's clinical portfolio and advanced more than 20 novel ...

Regulators are reviewing what could become a multi-billion-dollar drug.

Donald Trump has nominated vocal vaccine sceptic and former Democrat Robert Kennedy Jr as head of the US Department of Health and Human Services, the latest in a series of controv ...

The purchase of Alex Jones’ Infowars at a bankruptcy auction by the satirical news publication The Onion is the latest twist ...

A Sun Valley man was convicted Tuesday for his role in the killings of the mother and stepfather of a 17-year-old girl whom he met through the ...